Comparison of clinical outcomes of transjugular intrahepatic portosystemic shunt for refractory ascites and recurrent nonrefractory ascites

Table 1 Baseline characteristics of the four groups of patients

Characteristics	Group A, n = 183	Group B, n = 217	Group C, n = 328	Group D, n = 135
Gender, male/female	106/77	137/80	173/155	74/61
Age (year)	53.57 ± 11.62	51.27 ± 13.29	49.24 ± 10.34	51.15 ± 9.25
Child-Pugh A/B/C	13/114/56	0/69/148	0/221/107	0/18/117
MELD score	9.16 ± 3.46	10.37 ± 2.71	11.15 ± 1.41	11.27 ± 1.05
Viral hepatitis	135	162	272	112
Chronic ethanol consumption	31	34	32	14
Cryptogenic hepatitis	17	21	24	9
Laboratory tests
Alanine transaminase (U/L)	37.14 ± 8.17	41.27 ± 7.43	46.25 ± 11.38	48.36 ± 8.17
Aspartate transaminase (U/L)	43.74 ± 9.36	47.28 ± 8.49	54.16 ± 14.25	57.21 ± 12.04
Alkaline phosphatase (U/L)	119.43 ± 17.67	126.27 ± 14.17	124.16 ± 26.18	136.19 ± 21.51
γ-Glutamyl transpeptidase (U/L)	257.43 ± 29.28	262.46 ± 33.45	285.43 ± 27.65	247.32 ± 16.42
Total bilirubin (mol/L)	37.23 ± 6.54	45.13 ± 7.26	49.32 ± 12.17	54.72 ± 09.28
Albumin (g/L)	32.26 ± 2.35	29.14 ± 2.86	27.02 ± 1.54	24.37 ± 2.69
Prothrombin time (second)	15.16 ± 1.46	16.27 ± 1.24	16.18 ± 2.64	17.25 ± 1.31
Clinical presentation
Abdominal distention	167	194	283	103
Abdominal pain	26	38	43	17
Weakness	46	62	189	83
Poor appetite	135	152	315	132
Jaundice	24	37	35	16
Splenomegaly	147	169	317	129
Lower limb edema	132	163	289	116
Ascites paracentesis	176	217	321	135

Baseline characteristics were observed in terms of age, sex, Child-Pugh score, MELD score, laboratory tests and clinical presentation. MELD score: Model of End-Stage Liver Disease score.